ResearcherBeijing Geriatric HospitalNo recent work listed

Xiaolong Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7086-5339; OpenAlex author ID A5101552378. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study b… Co-author DOI 10.3389/fendo.2023.1225979 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiazhao Song · 1 shared paper, 2023 · strength 0.16
- Paper Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensi… DOI 10.3389/fendo.2023.1225979 ↗
Gang Ren · 1 shared paper, 2023 · strength 0.16
- Paper Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensi… DOI 10.3389/fendo.2023.1225979 ↗
Yingjie Wang · 1 shared paper, 2023 · strength 0.16
- Paper Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensi… DOI 10.3389/fendo.2023.1225979 ↗
Chen Liu · 1 shared paper, 2023 · strength 0.16
- Paper Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensi… DOI 10.3389/fendo.2023.1225979 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.